Often, a food-safe epoxy resin will indicate FDA approval on the company’s safety ... If you would like to mix with other products such as color and glitter, you will also need to understand ...

Some states have already moved to restrict some synthetic dyes and the FDA banned Red 3 from the nation’s food supply.

This approval is Biocon's seventh U.S. biosimilar, enhancing their oncology portfolio and commitment to affordable biologics. The FDA has approved Jobevne, a biosimilar to Avastin, for IV use in a ...

A settlement between Amgen and Fresenius Kabi will permit the biosimilar to launch in mid-2025 in the U.S. Perspective from Ruban Dhaliwal, MD, MPH The FDA has approved two new denosumab ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.

FOSTER CITY, Calif., April 14, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet ...

Several studies reported reduced itch severity and urticaria activity with dupilumab. The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria ...

Vitrakvi received full FDA approval for treating NTRK gene fusion-positive solid tumors in adults and children, following its initial accelerated approval in 2018. The drug functions as a tyrosine ...

At 3 years, Opdivo plus Yervoy led to an overall survival rate of 38% in patients with unresectable or metastatic hepatocellular carcinoma, compared to 24% with lenvatinib or sorafenib monotherapy.

“The approval of Livmarli in tablet form provides a meaningful additional treatment option for patients with ALGS and PFIC,” said Peter Radovich, president and chief operating officer at Mirum.

According to GSK, the last time the FDA cleared a new class of antibiotics for uncomplicated UTIs was in 1996, with the approval of fosfomycin. (Last year, the agency approved the drug Pivya for ...

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed improved ...